PAMORELIN LA subst sèche 22.5 mg c solv (adapt)
7680612380023
CH-61238
L02AE04
07.16.2.
Reimbursement limitations:
PAMORELIN.01
Cancer de la prostate hormono-dépendant au stade avancé.
Cancer de la prostate hormono-dépendant localisé à …
1 / 3
google
Details
- Product number
- 6123802
- CPT
- -
- Packaging group
- 1
- Unit
- Set
- Composition
- Praeparatio cryodesiccata: triptorelinum 22.5 mg ut triptorelini embonas, poly(lactidum-co-glycolidum) 75/25, poly(lactidum-co-glycolidum) 85/15, mannitolum, carmellosum natricum corresp. natrium 2.3 mg, polysorbatum 80, pro vitro. Solvens: aqua ad iniectabile 2 ml.
Articles (1)
Pamorelin LA 22.5 mg, poudre et solvant pour suspension injectable à libération prolongée
Poudre et solvant pour suspension injectable à libération prolongée
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLV
|
2.0 ML | Substance | HNIDK |
|
PRC
|
22.5 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | WIZUS |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
2.3 MG | Substance | HBESI |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 657.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2012
Authorization holder
Debiopharm Research & Manufacturing SA
1920 Martigny
Authorization information
- Swissmedic authorization number
- 61238
- Drug name
- Pamorelin LA 22.5 mg, poudre et solvant pour suspension injectable à libération prolongée
- Galenic form
- PULMS
- ATC Code
- L02AE04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 09/03/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PAMORELIN LA subst sèche 22.5 mg c solv (adapt)
- Description (DE)
- PAMORELIN LA Trockensub 22.5 mg c Solv (Adapter)
- Market launch
- 07/09/2018
- Narcotic (BTM)
- No